Tranexamic Acid Injection, Solution
Product Images NDC 51662-1714

3 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 51662-1714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Table (51662 1714 1 Table 1.png)

Table (51662 1714 1 Table 1.png)
A table titled 'Recommended Dosage in Patients with Varying Degrees of Renal Impairment' showing Tranexamic Acid Injection Intravenous Dosage guidelines. It lists serum creatinine ranges in mg/dL and corresponding dosages: 10 mg/kg twice daily for 1.36 to 2.83, 10 mg/kg daily for 2.83 to 5.66, and 10 mg/kg every 48 hours or 5 mg/kg every 24 hours for above 5.66. A note states dose reduction is recommended for all doses before and after tooth extraction.*
FDA Label Image

Structure (51662 1714 Structure)

Structure (51662 1714 Structure)
Chemical structure of tranexamic acid showing its cyclohexane ring with an amino group and carboxylic acid functional groups attached.*
FDA Label Image

Vial (51662 1714 1 Vial)

Vial (51662 1714 1 Vial)
Label for TRANEXAMIC ACID injection solution includes GS1 barcode and numeric identifiers. Text states to see the manufacturer's insert and notes distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275 with an Rx only designation. No strength or dosage form specifics are visible on this label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.